Gentherm Incorporated
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a THRM research report →
Range $34 – $59
Price Chart
About the company
Gentherm Incorporated is a company dedicated to the creation, production, and sale of advanced thermal management technologies. Its operations are divided into two principal business segments: Automotive and Medical. The Automotive segment offers an extensive range of climate comfort systems, encompassing active heating and cooling solutions for seats (utilizing heaters, blowers, and thermoelectric devices for precise temperature regulation), heated steering wheels, and specialized thermal comfort products for areas like the neck, door panels, armrests, cupholders, and storage bins.
- CEO
- William T. Presley
- IPO
- 1993
- Employees
- 14,000
- HQ
- Northville, MI, US
Get TickerSpark's AI analysis on THRM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.25B
- P/E
- 46.85
- Fwd P/E
- 13.93
- PEG
- -3.19
- P/S
- 0.79
- P/B
- 1.72
- EV/EBITDA
- 11.88
- Div Yield
- 0.00%
- Gross Margin
- 23.43%
- Op Margin
- 3.74%
- Net Margin
- 1.69%
- ROE
- 3.69%
- ROIC
- 3.15%
Latest fiscal year · YoY change
- Revenue
- $1.49B+2.6%
- Gross Profit
- $351.67M-4.0%
- Op Income
- $78.05M
- Net Income
- $18.29M-71.8%
- EPS
- $0.60-71.2%
- OCF Growth
- +6.5%
- FCF Growth
- +68.2%
- 52W High
- $48.35
- 52W Low
- $27.00
- 50D MA
- $38.21
- 200D MA
- $34.48
- Beta
- 1.35
- RSI (14)
- 50
- Avg Volume
- 422.15K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Gentherm raised full-year 2026 guidance after a strong Q2, led by record revenue, solid auto outperformance, and momentum in new markets and the Modine-related transformation.· July 23, 2026
- Q2 revenue hit a quarterly record of $416 million, up 11% year over year, with auto climate and comfort sales up 14.1%.
- Adjusted EBITDA was $48.8 million, or 11.7% of sales, while adjusted diluted EPS rose to $0.75 from $0.54 a year ago.
- Management raised 2026 guidance for revenue, adjusted EBITDA, and adjusted free cash flow, citing strong first-half execution and second-half visibility.
- Automotive new business awards were about $690 million in Q2 and more than $1 billion year to date.
- The company highlighted expansion beyond light vehicles, including home and office wins, ThermAffyx FDA clearance, and the $34 million IME acquisition.
Revenue was $416 million in Q2, up 11% year over year, or up 9.5% excluding FX. Automotive Climate and Comfort Solutions revenue grew 14.1% year over year, or 12.7% ex-FX, and lumbar and massage comfort solutions grew 38%. Adjusted EBITDA was $48.8 million, or 11.7% of sales, versus 12.2% a year ago. Reported diluted EPS was $0.14, impacted by about $0.55 per share of merger and restructuring expenses; adjusted diluted EPS was $0.75, up 39% from $0.54. Management raised 2026 full-year guidance to revenue of $1.6 billion at the midpoint, adjusted EBITDA of $185 million to $200 million, and adjusted free cash flow of $85 million to $100 million; CapEx is guided to $45 million to $55 million, or about 3% of sales.
Bill Presley said the company had an excellent first half, driven by strong commercial execution and operational discipline, and that Gentherm is outperforming the market while improving its operating system. He emphasized that the business is gaining traction beyond light vehicles through home and office wins, ThermAffyx, and the IME acquisition, while the Modine combination should create a more diversified company with greater scale and long-term growth potential. His tone was confident and upbeat, but he also noted ongoing attention to macro and geopolitical uncertainty and inflationary pressures.
Jon Douyard said Q2 revenue of $416 million was ahead of expectations, with broad-based auto strength and strong China performance helping drive the beat. He highlighted adjusted EBITDA of $48.8 million, a 11.7% margin, and said margins were pressured by inflation recovery timing, planned inventory reductions, and warranty accruals in automotive and medical. He also pointed to adjusted free cash flow of about $16 million year to date, CapEx of $14 million, net leverage of 0.3 turns, liquidity of $502 million, and the new $800 million financing package supporting the Modine deal; post-close, net leverage is expected around 1 turn, with a target of 1x to 1.5x over time.
Analysts asked where the auto outperformance came from, and management said it was broad-based across regions and products, with China particularly strong, while reaffirming confidence in mid-single-digit over-market growth over time. On home and office, management said the new North American wins were large, the TAM is over $500 million, and the company still sees $50 million to $100 million of revenue by 2028. Questions on IME and ThermAffyx focused on market traction and cross-selling: Gentherm said IME’s $34 million purchase price fits a business with projected 2026 revenue of about $17 million and 20% EBITDA margins, and it sees more than $100 million of cross-selling potential by 2030; ThermAffyx demand was described as strong, with initial sales expected in Q3. Management also said an auto warranty issue is specific to one product/customer and not viewed as part of the ongoing run rate.
The call suggested Gentherm is executing well operationally and commercially, with revenue and awards both running ahead of plan and guidance moving up. Management also showed confidence that the company can expand beyond automotive through home and office, medical, and the Modine combination, while maintaining strong balance-sheet flexibility and capital return capacity.
Management acknowledged some second-half headwinds, including tougher comps, runoff businesses, and lower margins in Q3 before a rebound in Q4. They also flagged inflation recovery timing, inventory reductions, and warranty accruals as pressure points, and the Modine transaction still needs to close early in Q4 before the diversification and synergy story is realized.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 97.8%
- Shares Outstanding
- 30.71M
- Float Shares
- 30.03M
of shares held by institutions
243 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for THRM, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Thom TillisSenate · NC | Sell | Feb 13, 15 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 4.84M | ▲ 140.54K |
| Vanguard Group Inc | 3.33M | ▲ 29.21K |
| Dimensional Fund Advisors LP | 1.57M | ▲ 93.80K |
| Harvey Partners, LLC | 1.33M | ▲ 92.58K |
| State Street Corp | 1.31M | ▲ 66.02K |
| Vanguard Capital Management LLC | 1.31M | ▲ 24.06K |
| Segall Bryant & Hamill, LLC | 1.30M | ▲ 379.88K |
| Global Alpha Capital Management Ltd. | 1.19M | ▼ 4.84K |
| Trigran Investments, Inc. | 1.16M | ▼ 184.16K |
| Fuller & Thaler Asset Management, Inc. | 1.13M | ▼ 38.67K |
| American Century Companies Inc | 894.09K | ▲ 131.65K |
| Geode Capital Management, LLC | 818.63K | ▲ 47.48K |
Held by 279 ETFs
Biggest fund positions in THRM by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 17, 26 | Nicholas Breisacher | sell | 925 |
| Jul 29, 26 | Kauffman Wayne S III | sell | 4,700 |
| May 14, 26 | Washington Kenneth E | other | 4,292 |
| May 14, 26 | Stacey John | other | 4,292 |
| May 14, 26 | Meter Elizabeth | other | 4,292 |
| May 14, 26 | Kummeth Charles R. | other | 4,292 |
| May 14, 26 | Kowalchik Laura Michele | other | 4,292 |
| May 14, 26 | Hundzinski Ronald T | other | 4,292 |
| May 14, 26 | Heinzmann David W | other | 4,292 |
| May 14, 26 | Desormiere Sophie | other | 4,292 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our THRM coverage
Recent articles, reports, and earnings notes.
No research on THRM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate THRM report →Gentherm Targets $3.5B Revenue as Modine Deal Expands Beyond Autos
marketbeat.com · Aug 17
Gentherm Incorporated (THRM) Presents at J.P. Morgan Automotive Conference Transcript
seekingalpha.com · Aug 13
Is Gentherm (THRM) a Great Value Stock Right Now?
zacks.com · Aug 13
Gentherm Inc (THRM) Shares Fall 4.1% -- What GF Score of 92 Tells Investors
gurufocus.com · Jul 31
Gentherm Announces Participation in J.P. Morgan Auto Conference and Seaport Annual Summer Investor Conference
globenewswire.com · Jul 30
Should Value Investors Buy Gentherm (THRM) Stock?
zacks.com · Jul 28
Gentherm (THRM) Shows Fast-paced Momentum But Is Still a Bargain Stock
zacks.com · Jul 28
Gentherm (NASDAQ:THRM) to Repurchase $400.00 million in Stock
defenseworld.net · Jul 24
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.